TICKERNERD
Menu
TDOCTDOCHealthcare · Health Information Services

TDOC Stock Forecast: Teladoc Health, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$6.39
−1.54% on the day

The 24 Wall Street analysts covering Teladoc Health, Inc. hold a median 12-month price target of $7.5 — +17.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 68 of 100 as at 21 Aug 2026 — in the upper half.

Market cap
$1.2B
Ticker Nerd rank
68 / 100
Median analyst target
$7.50
Analysts covering
24
Total return, dividends reinvested
1W
−6.2%
1M
−34.2%
YTD
−8.7%
1Y
−11.1%
From 52W high
−34.3%
From 52W low
+43.0%
$4.47
$9.72
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

TDOC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Teladoc Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Aug 2026
68 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
97
Quality
79
Value
79
Growth
61
Revisions
45
Momentum
45
Size
44
Issuance
43
Volatility
23

Accruals (97): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (23): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

TDOC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on TDOC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4.00$5.00$6.00$7.00$8.00$9.00$10.00$11.00Oct 25Jan 26Apr 26Jul 26TDOCHigh $10.50Median $7.50Low $5.50

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says24 analysts
6 Buy18 Hold0 Sell
Low $5.50Median $7.50High $10.50

The green dot is the last close — the median target sits +17.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
3 Aug 2026CitigroupMaintainsNeutral$11 → $7.50
30 July 2026Canaccord GenuityMaintainsBuy$11 → $10
30 July 2026Evercore ISI GroupMaintainsIn-Line$10 → $7.50
21 July 2026Canaccord GenuityMaintainsBuy$10 → $11
21 July 2026Canaccord GenuityMaintainsBuy—
7 July 2026B of A SecuritiesMaintainsBuy$9.00 → $11
7 July 2026B of A SecuritiesMaintainsBuy—
5 May 2026CitigroupMaintainsNeutral—
8 Apr 2026Evercore ISI GroupMaintainsIn-Line—
26 Mar 2026BarclaysMaintainsEqual-Weight—
13 Mar 2026JP MorganMaintainsNeutral—
10 Mar 2026Deutsche BankUpgradeBuy—
3 Mar 2026CitigroupMaintainsNeutral—
3 Mar 2026OppenheimerMaintainsOutperform—
26 Feb 2026BMO CapitalMaintainsMarket Perform—
26 Feb 2026Canaccord GenuityMaintainsBuy—
26 Feb 2026Evercore ISI GroupMaintainsIn-Line—
26 Feb 2026Leerink PartnersMaintainsMarket Perform—
26 Feb 2026Piper SandlerReiteratesOverweight—
26 Feb 2026StifelMaintainsHold—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. TDOC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

TDOC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
2
Fundamentals

Teladoc Health, Inc. (TDOC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−5.7×

Cheaper than 90% of US stocks

Price / sales
0.5×

Cheaper than 83% of US stocks

Price / book
0.9×

Cheaper than 77% of US stocks

EV / EBITDA
22.8×

Cheaper than 13% of US stocks

Growth & margins
Revenue growth (YoY)
−4.0%

Higher than 21% of US stocks

Earnings growth (YoY)
−4.0%

Higher than 31% of US stocks

Gross margin
68.6%

Higher than 82% of US stocks

Operating margin
−5.7%

Higher than 27% of US stocks

Net margin
−7.1%

Higher than 22% of US stocks

Returns & dividend
Return on equity
−13.0%

Higher than 34% of US stocks

Return on assets
−3.2%

Higher than 34% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

TDOC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
TDOCTeladoc Health, Inc.$1.2B
68
GDRXGoodRx Holdings, Inc.$1.2B
75
CERTCertara, Inc.$1.3B
55
OMDAOmada Health, Inc.$1.4B
85
TALKTalkspace, Inc.$879.4M
—
SDGRSchrödinger, Inc.$1.5B
53
HSTMHealthStream, Inc.$856.5M
94

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Teladoc Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest TDOC news & analysis

Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 17 Aug 2026negative

A press release announces that shareholders of Teladoc Health, Inc. are being urged to contact a law firm regarding a potential breach of fiduciary duties by the company's insiders. The firm states it would handle the matter on a contingent fee basis with no out-of-pocket costs for shareholders.

Why it matters — A TDOC watcher would care because the notice signals a possible shareholder legal action against the company's insiders that could carry governance and legal implications.

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

PRNewsWire · 7 Aug 2026negative

Teladoc Health shares fell more than 28% after the company reported Q2 2026 revenue of $606.9 million and cut its full-year 2026 revenue guidance. Levi & Korsinsky has announced a securities investigation into the company.

Why it matters — TDOC watchers would care because the sharp share decline and guidance cut have triggered a securities investigation into the company.

Teladoc Health Inc. (TDOC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Business Wire · 6 Aug 2026negative

Law Offices of Howard G. Smith announced an investigation into Teladoc Health Inc. over potential violations of federal securities laws, inviting investors who suffered losses to contact the firm about pursuing claims.

Why it matters — The investigation signals potential legal and reputational risk for Teladoc related to possible securities law violations.

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

Business Wire · 5 Aug 2026negative

The Law Offices of Frank R. Cruz announced a securities fraud investigation into Teladoc Health Inc. concerning possible violations of federal securities laws, urging investors who lost money to contact the firm. The investigation follows the Company's second-quarter earnings report on July 29, 2025.

Why it matters — TDOC shareholders should be aware that the company is now facing a formal securities fraud investigation, which could lead to litigation and reputational damage.

TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)

Business Wire · 4 Aug 2026negative

Teladoc reduced its full-year 2026 consolidated revenue outlook from $2.47 billion-$2.59 billion to $2.36 billion-$2.45 billion, and its shares fell nearly 30%. Law firm Levi & Korsinsky has notified investors that it is investigating the company and invited those who lost money to submit their information.

Why it matters — A TDOC watcher would care because the lowered revenue guidance and sharp share decline have prompted a law firm investigation into the company, adding potential legal scrutiny for shareholders.

FAQ

Frequently asked questions about TDOC stock

What is the TDOC stock price forecast for 2026-2027?

The 24 Wall Street analysts covering Teladoc Health, Inc. have a median 12-month price target of $7.5, with estimates ranging from $5.5 to $11. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is TDOC stock a buy right now?

Of the 24 analysts covering Teladoc Health, Inc., 6 rate it a Buy, 18 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Teladoc Health, Inc. 68 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank TDOC?

As at 21 Aug 2026, Teladoc Health, Inc. ranks 68 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (97 of 100).

Will TDOC stock go up?

No one can know that. What the data says: the median 12-month target from 24 analysts implies +17.4% from the last close, and Ticker Nerd's factor model ranks Teladoc Health, Inc. 68 out of 100 as at 21 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the TDOC stock forecast for 2030?

No analyst covering Teladoc Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TDOC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5.5 to $11 over the next 12 months.

How has TDOC stock performed over the past year?

Teladoc Health, Inc. returned -11.1% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Teladoc Health, Inc. do?

Teladoc Health Inc. is a virtual healthcare company that provides comprehensive medical and mental health services through digital channels.

What is the latest news on TDOC?

The most recent item we track (PRNewsWire, 17 Aug 2026): "Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?". A press release announces that shareholders of Teladoc Health, Inc. are being urged to contact a law firm regarding a potential breach of fiduciary duties by the company's insiders. The firm states it would handle the matter on a contingent fee basis with no out-of-pocket costs for shareholders.

Company

About Teladoc Health, Inc.

Teladoc Health Inc. is a virtual healthcare company that provides comprehensive medical and mental health services through digital channels. The company’s primary function is to connect patients with licensed clinicians via phone, video, and mobile applications for non-emergency medical care, behavioral health, and chronic condition management. Teladoc Health operates two main business segments: Integrated Care, which serves employers, health plans, hospitals, and health systems with a suite of virtual medical services and care management programs; and BetterHelp, a direct-to-consumer online therapy platform offering subscription-based access to licensed therapists. Its offerings span general medical telehealth, virtual primary care, expert medical opinions, hospital-focused virtual care workflows, and telehealth devices that support clinical collaboration. Headquartered in New York City and founded in 2002 in the United States, Teladoc Health plays a significant role in the digital health ecosystem by enabling organizations and individuals to integrate virtual care into existing benefits and care delivery models, expanding access and facilitating coordinated, whole-person care across multiple regions worldwide.

CEO Mr. Charles Divita III, CPA · 4,648 employees · United States · https://www.teladochealth.com